[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353688-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353688-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","long-term-outcomes-of-the-indian-childhood-cancer-survivorship-c2s-cohort-a-multicentre-study-20162024","Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort - a multicentre study (2016–2024)","","Long term outcomes of childhood cancer survivorship are assessed through the Indian Childhood Cancer Survivorship (C2S) Study, designed to build a nationwide survivor cohort and systematically capture treatment exposures and late effects. The prospective multicentre observational study enrolled children diagnosed before age 18 and in remission, with centralized monitoring and follow-up every three months to track survival, relapse, and abandonment. By December 2024, data covered 20 centres and thousands of survivors, with survival and event-free survival estimates reported for the full cohort.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/long-term-outcomes-of-the-indian-childhood-cancer-survivorship-c2s-cohort-a-multicentre-study-20162024/353688/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/long-term-outcomes-of-the-indian-childhood-cancer-survivorship-c2s-cohort-a-multicentre-study-20162024/353688.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the goal of the Indian Childhood Cancer Survivorship (C2S) Study?","Question",{"text":63,"@type":64},"It was designed to build a nationwide survivor cohort and systematically capture treatment exposures and long-term outcomes and late effects.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants selected and followed in the C2S study?",{"text":68,"@type":64},"Children diagnosed before age 18 and in remission after treatment were enrolled, and follow-up occurred every three months to assess survival, relapse, and abandonment.",{"name":70,"@type":61,"acceptedAnswer":71},"What outcomes were reported as of December 2024?",{"text":72,"@type":64},"Data included survivors from 20 centres across India, with overall survival and event-free survival rates reported for the entire cohort, alongside common treatment exposures and diagnoses.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353688,1790161497,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Articles  \nLong term outcomes of the Indian childhood cancer  \nsurvivorship (C2S) cohort: a multicentre study (2016–2024)  \nRachna Seth,a,∗ Gauri Kapoor,b,c Nirmalya Roy Moulik,d Prakruthi Kaushik,e Nishant Verma,f Amita Mahajan,g Priyakumari T,h Nita Radhakrishnan,i Revathi Raj,j Amitabh Singh,k Sujata Sharma,l Venkatraman Radhakrishnan,m Sirishia Rani,n  \nParthasarathi Bhattacharyya,o Yamini Krishnan,p Piali Mandal,q Emine A. Rahiman,r Prachi Jain,s Debasish Sahoo,t Debabrata Mohapatra,u Gargi Das,m Vineeta Gupta,v Gurpreet Singh,w Shruti Kakkar,x Anuj Singh,i Prashant Prabhakar,k Arun Kumar AR,y Jagdish Prasad Meena,u Aditya Kumar Gupta,u Payal Malhotra,z Chandan Kumar,aa Siyaram Didel,ab Shilpa Khanna Arora,ac Veerendra Patil,ad Anand Prakash,ae Purva Kanvinde,af Maya Prasad,d Jagdish Chandra,ag Purna Kurkure,ah and Ramandeep Aroraai  \naChief Oncology Division, Department of Pediatrics, AIIMS, New Delhi, India bRajiv Gandhi Cancer Institute and Research Centre, Nitibagh, New Delhi, India  \ncDepartment of Pediatric Hematology Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Rohini Sector 5, 110085, Delhi, India  \ndPediatric Oncology, Tata Memorial Hospital, Dr. E Borges Road, Parel, Mumbai, IndiaeDepartment of Pediatric Oncology, Kidwai Institute of Medical Oncology, Bengaluru, India fDepartment of Pediatrics, King George Medical University, Lucknow, India  \ngPediatric Hematology/Oncology, Indraprastha Apollo Hospitals, New Delhi, India  \nhDepartment of Pediatric Oncology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India iDepartment of Pediatric Hematology Oncology, Post Graduate Institute of Child Health, Noida, India jPediatric Hematology-Oncology, Apollo Specialty Hospitals, Chennai, India  \nkVMMC & Safdarjung Hospital, New Delhi, India  \nlHematology-Oncology & BMT Unit, LTMMC & LTMGH, Sion, Mumbai, India mDepartment of Medical Oncology, Cancer Institute (W.I.A) Chennai, India  \nnConsultant in Pediatric Hematology Oncology, Rainbow Children’s Hospital, Hyderabad, India  \noPediatric Hematology-Oncology, Tata Medical Centre, Kolkata, India  \npDepartment of Pediatric Hematology Oncology, MVR Cancer Centre and Research Institute, Kerala, India qDepartment of Pediatrics, Lady Hardinge Medical College and Kalawati Saran Children’s Hospital, New Delhi, India rDepartment of Pediatric Hematology and Oncology, Kasturba Medical College, Manipal, India  \nsDepartment of Pediatric Hematology and Oncology, Max Super Specialty Hospital, Patparganj, New Delhi, India tDepartment of Hematology and Medical Oncology, All India Institute of Medical Sciences, Bhubaneswar, India uDivision of Pediatric Oncology, Department of Pediatrics, AIIMS, New Delhi, India  \nvDivision of Pediatric Hematology-Oncology/BMT, Department of Pediatrics, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India  \nwPediatric Hemato-Oncology, DMCH, Ludhiana, India  \nxClinical Hematology and Stem Cell Transplant Unit, Christian Medical College & Hospital, Ludhiana, India yDepartment of Pediatric Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India  \nzDepartment of Pediatric Hematology-Oncology, Rajiv Gandhi Cancer Institute & Research Centre, Rohini Sector 5, New, 110085, Delhi, India  \naaResonance Health, India  \nabDepartment of Pediatrics, All India Institute of Medical Science, Jodhpur, India  \nacDivision of Pediatric Hematology & Oncology, Department of Pediatrics, ABVIMS & Dr RML Hospital, New Delhi, India adBasavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, India  \naeDepartment of Pediatric Hematology, Oncology & Bone Marrow Transplant, St. John’s Medical College, Bengaluru, India afDepartment of Pediatric Hematology-Oncology, B J Wadia Hospital for Children, Mumbai, India  \nagDepartment of Pediatrics, ESIC Medical College and Hospital, Faridabad, India  \nahPediatric Haemato- Oncology & BMT, SRCC Children’s Hospital Narayana Health, Mumbai, India  \naiPaediatric Oncology, Max Super Spec","cbCaieQNu2iSZlPH","https://ap.wps.com/l/cbCaieQNu2iSZlPH","pdf",1224175,11,"English","# Summary\n## Background\n## Methods\n## Findings","[{\"question\":\"What is the goal of the Indian Childhood Cancer Survivorship (C2S) Study?\",\"answer\":\"It was designed to build a nationwide survivor cohort and systematically capture treatment exposures and long-term outcomes and late effects.\"},{\"question\":\"How were participants selected and followed in the C2S study?\",\"answer\":\"Children diagnosed before age 18 and in remission after treatment were enrolled, and follow-up occurred every three months to assess survival, relapse, and abandonment.\"},{\"question\":\"What outcomes were reported as of December 2024?\",\"answer\":\"Data included survivors from 20 centres across India, with overall survival and event-free survival rates reported for the entire cohort, alongside common treatment exposures and diagnoses.\"}]","Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort - a multicentre study (2016–2024) | PDF",1790106746,28,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/32520baa85d0d553cf6057db199c59ce.webp",983,1310,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acde57fb41db48632281ee96099bb893.webp",982,1309,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bcd62cafdf03e01ebeb5711ac060daa1.webp",981,1308,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64da460223200ba82b9349a6bf95bc0f.webp",980,1306]